Search
SUTENT 12.5 MG, Gélule
Details
| --- | Description |
|---|---|
| Pack | Boîte de 30 |
| Strength (Dosage) | 12.5 MG |
| Laboratory | PFIZER MAROC |
| Ingredients | Sunitinib |
| Therapeutic class | Antinéoplasique, inhibiteur de multikinase |
| ATC code | L01XE04 |
| PPH | $973.30 |
| PPV | $992.00 |
| Refundable | Yes |
| Refund base | $992.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Traitement de patients atteints de carcinome rénal avancé et/ou métastatique (RCC). Traitement de patients atteints de tumeurs stromales gastro-intestinales malignes (GIST) en cas de résistance ou d'intolérance à l'imatinib. Traitement de patients atteints de carcinome neuro-endocrine du pancréas, non résécable, bien différencié, avancé et/ou métastatique (pancreatic NET). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem